Application
Potent, ATP-competitive. IC50 = 0.23 µM. Selectivity over other PI3K-related kinases (IC50 = 13 µM for PI3K and >100 µM for ATM and ATR).
NU7026 has been used:as a DNA-dependent protein kinase (DNA-PK) inhibitor, to pre-treat colon cancer cellin kinase inhibitor experiments for treating zygotes with visible pronuclei post 20 h-human chorionic gonadotropin (hCG)to determine its influence on cytotoxicity of dibenzo[def,p]chrysene on HepG2 cells
Biochem/physiol Actions
Cell permeable, small molecule benzochromenone inhibitor of DNA-PK (DNA dependent protein kinase).
Packaging
5 mg in glass bottle
This product has met the following criteria to qualify for the following awards: